Literature DB >> 18292383

Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging.

Christopher M Holland1, Eric E Smith, Istvan Csapo, Mahmut Edip Gurol, Douglas A Brylka, Ronald J Killiany, Deborah Blacker, Marilyn S Albert, Charles R G Guttmann, Steven M Greenberg.   

Abstract

BACKGROUND AND
PURPOSE: White-matter hyperintensities (WMHs) detected by magnetic resonance imaging are thought to represent the effects of cerebral small-vessel disease and neurodegenerative changes. We sought to determine whether the spatial distribution of WMHs discriminates between different disease groups and healthy aging individuals and whether these distributions are related to local cerebral perfusion patterns.
METHODS: We examined the pattern of WMHs by T2/fluid-attenuated inversion recovery-weighted magnetic resonance imaging in 3 groups of subjects: cerebral amyloid angiopathy (n=32), Alzheimer disease or mild cognitive impairment (n=41), and healthy aging (n=29). WMH frequency maps were calculated for each group, and spatial distributions were compared by voxel-wise logistic regression. WMHs were also analyzed as a function of normal cerebral perfusion patterns by overlaying a single photon emission computed tomography atlas.
RESULTS: Although WMH volume was greater in cerebral amyloid angiopathy and Alzheimer disease/mild cognitive impairment than in healthy aging, there was no consistent difference in the spatial distributions when controlling for total WMH volume. Hyperintensities were most frequent in the deep periventricular WM in all 3 groups. A strong inverse correlation between hyperintensity frequency and normal perfusion was demonstrated in all groups, demonstrating that WMHs were most common in regions of relatively lower normal cerebral perfusion.
CONCLUSIONS: WMHs show a common distribution pattern and predilection for cerebral WM regions with lower atlas-derived perfusion, regardless of the underlying diagnosis. These data suggest that across diverse disease processes, WM injury may occur in a pattern that reflects underlying tissue properties, such as relative perfusion.

Entities:  

Mesh:

Year:  2008        PMID: 18292383      PMCID: PMC2754400          DOI: 10.1161/STROKEAHA.107.497438

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  45 in total

1.  Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.

Authors:  K A Knudsen; J Rosand; D Karluk; S M Greenberg
Journal:  Neurology       Date:  2001-02-27       Impact factor: 9.910

2.  Cerebral perfusion and cerebrovascular reactivity are reduced in white matter hyperintensities.

Authors:  J R Marstrand; E Garde; E Rostrup; P Ring; S Rosenbaum; E L Mortensen; H B W Larsson
Journal:  Stroke       Date:  2002-04       Impact factor: 7.914

3.  Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD.

Authors:  M Yoshita; E Fletcher; D Harvey; M Ortega; O Martinez; D M Mungas; B R Reed; C S DeCarli
Journal:  Neurology       Date:  2006-12-26       Impact factor: 9.910

4.  Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study.

Authors:  C DeCarli; B L Miller; G E Swan; T Reed; P A Wolf; D Carmelli
Journal:  Arch Neurol       Date:  2001-04

5.  Predicting conversion to Alzheimer disease using standardized clinical information.

Authors:  E Daly; D Zaitchik; M Copeland; J Schmahmann; J Gunther; M Albert
Journal:  Arch Neurol       Date:  2000-05

Review 6.  Alzheimer disease as a vascular disorder: nosological evidence.

Authors:  J C de la Torre
Journal:  Stroke       Date:  2002-04       Impact factor: 7.914

7.  Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  R C Petersen; J C Stevens; M Ganguli; E G Tangalos; J L Cummings; S T DeKosky
Journal:  Neurology       Date:  2001-05-08       Impact factor: 9.910

Review 8.  Vascular risk factors for Alzheimer's disease: an epidemiologic perspective.

Authors:  M M Breteler
Journal:  Neurobiol Aging       Date:  2000 Mar-Apr       Impact factor: 4.673

9.  Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis.

Authors:  M O'Sullivan; D J Lythgoe; A C Pereira; P E Summers; J M Jarosz; S C R Williams; H S Markus
Journal:  Neurology       Date:  2002-08-13       Impact factor: 9.910

10.  Cerebral amyloid angiopathy, white matter lesions and Alzheimer encephalopathy - a histopathological assessment.

Authors:  Mattias Haglund; Elisabet Englund
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

View more
  93 in total

1.  Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort.

Authors:  Adam M Brickman; Christiane Reitz; José A Luchsinger; Jennifer J Manly; Nicole Schupf; Jordan Muraskin; Charles DeCarli; Truman R Brown; Richard Mayeux
Journal:  Arch Neurol       Date:  2010-05

2.  Correlations between MRI white matter lesion location and executive function and episodic memory.

Authors:  E E Smith; D H Salat; J Jeng; C R McCreary; B Fischl; J D Schmahmann; B C Dickerson; A Viswanathan; M S Albert; D Blacker; S M Greenberg
Journal:  Neurology       Date:  2011-04-26       Impact factor: 9.910

3.  An MRI-based semiquantitative index for the evaluation of brain atrophy and lesions in Alzheimer's disease, mild cognitive impairment and normal aging.

Authors:  Wei Chen; Xiaowei Song; Yunting Zhang; Sultan Darvesh; Ningnannan Zhang; Ryan C N D'Arcy; Sandra Black; Kenneth Rockwood
Journal:  Dement Geriatr Cogn Disord       Date:  2010-08-21       Impact factor: 2.959

4.  White matter hyperintensities predict functional decline in voiding, mobility, and cognition in older adults.

Authors:  Dorothy B Wakefield; Nicola Moscufo; Charles R Guttmann; George A Kuchel; Richard F Kaplan; Godfrey Pearlson; Leslie Wolfson
Journal:  J Am Geriatr Soc       Date:  2010-01-26       Impact factor: 5.562

Review 5.  Leukoaraiosis and stroke.

Authors:  Eric E Smith
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

6.  Neurovascular decoupling is associated with severity of cerebral amyloid angiopathy.

Authors:  Stefano Peca; Cheryl R McCreary; Emily Donaldson; Gopukumar Kumarpillai; Nandavar Shobha; Karla Sanchez; Anna Charlton; Craig D Steinback; Andrew E Beaudin; Daniela Flück; Neelan Pillay; Gordon H Fick; Marc J Poulin; Richard Frayne; Bradley G Goodyear; Eric E Smith
Journal:  Neurology       Date:  2013-10-04       Impact factor: 9.910

7.  An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease.

Authors:  Lidia Sarro; Nirubol Tosakulwong; Christopher G Schwarz; Jonathan Graff-Radford; Scott A Przybelski; Timothy G Lesnick; Samantha M Zuk; Robert I Reid; Mekala R Raman; Bradley F Boeve; Tanis J Ferman; David S Knopman; Giancarlo Comi; Massimo Filippi; Melissa E Murray; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Clifford R Jack; Kejal Kantarci
Journal:  Alzheimers Dement       Date:  2016-08-10       Impact factor: 21.566

8.  Postmortem brain MRI is related to cognitive decline, independent of cerebral vessel disease in older adults.

Authors:  Robert J Dawe; Lei Yu; Julie A Schneider; Konstantinos Arfanakis; David A Bennett; Patricia A Boyle
Journal:  Neurobiol Aging       Date:  2018-05-23       Impact factor: 4.673

9.  Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study.

Authors:  M Edip Gurol; Anand Viswanathan; Christopher Gidicsin; Trey Hedden; Sergi Martinez-Ramirez; Andrew Dumas; Anastasia Vashkevich; Alison M Ayres; Eitan Auriel; Ellis van Etten; Alex Becker; Jeremy Carmasin; Kristin Schwab; Jonathan Rosand; Keith A Johnson; Steven M Greenberg
Journal:  Ann Neurol       Date:  2013-02-19       Impact factor: 10.422

10.  Different strategies for auditory word recognition in healthy versus normal aging.

Authors:  C J Aine; J E Bryant; J E Knoefel; J C Adair; B Hart; C H Donahue; R Montaño; R Hayek; C Qualls; D Ranken; J M Stephen
Journal:  Neuroimage       Date:  2009-12-03       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.